[Mezlocillin in short-term obstetrico-gynecologic prophylaxis].
The present study examines a sample of 98 patients aged 18-77 (mean age 57) and awaiting obstetric or gynaecological surgery who were given short-term prophylaxis with mezlocillin. The overall success rate was 83.67%, partial success 14.28% (against 81% in the controls). In addition to the benefits of a shorter hospital stay and lower operating costs, the treatment produced no side effects.
Boemi
P
P
Reitano
S
S
Cilano
L
L
Platania
R
R
Rizzari
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D002444:Cefuroxime / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002585:Cesarean Section; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005836:Genitalia, Female / Q000601:surgery; D006176:Gynecology; D006801:Humans; D008802:Mezlocillin / Q000627:therapeutic use*; D008875:Middle Aged; D009774:Obstetrics; D011247:Pregnancy; D011292:Premedication; D013997:Time Factors
D002511:Cephalosporins; D002444:Cefuroxime; D008802:Mezlocillin
La mezlocillina nella profilassi ostetrico-ginecologica short-term.